Article
Megakaryocyte-targeted synthesis of the integrin beta(3)-subunit results in the phenotypic correction of Glanzmann thrombasthenia.
Blood - 15 Jun 2000
Wilcox D A, Olsen J C, Ishizawa L, Bray P F, French D L, Steeber D A, Bell W R, Griffith M, White G C
Abstract excerpt
Glanzmann thrombasthenia is an inherited bleeding disorder characterized by qualitative or quantitative defects of the platelet-specific integrin, alphaIIbbeta(3). As a result, alphaIIbbeta(3) cannot be activated and cannot bind to fibrinogen, leading to a loss of platelet aggregation. Thrombasthenia is clinically characterized by mucocutaneous hemorrhage with episodes of intracranial and gastrointestinal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
